U.S. Markets closed

GW Pharmaceuticals: Recommendations and Market Capitalization

Mike Benson
GW Pharmaceuticals: Recommendations and Market Capitalization

GW Pharmaceuticals (GWPH) has developed prescription medicines derived from the cannabis plant for the treatment of spasticity from multiple sclerosis. Its portfolio includes clinical stage cannabinoid products focused on the treatment of neurological conditions.